Invitae Invitae Sues Natera Alleging Infringement of Patent on DNA Sequencing Assembly Technique Invitae believes its '799 patent improves upon prior art and wants a US District Court to find that Natera is infringing its IP with its Signatera test. Invitae Q1 Revenues Increase 61 Percent The company reported revenues of $103.6 million, exceeding the consensus Wall Street estimate. Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy The testing program will be available for patients in the US who have symptoms or a diagnosis of cerebral palsy but no evidence of brain injury. Invitae to Provide Genetic Testing Within eMERGE Population Screening Study As a new clinical affiliate, Invitae will test up to 25,000 patients in a study exploring the role of genetics in cancer, heart disease, and other conditions. Invitae Acquiring Genosity for $200M; Investment Group Provides Firm $1.15B in Senior Notes Invitae expects that Genosity's software and data management platform will allow it to quickly advance several oncology tests in development. Mar 30, 2021 Renal Cell Carcinoma Risk Gene Representation Can Vary With Ancestry Feb 17, 2021 Invitae Q4 2020 Revenues Increase 51 Percent Feb 1, 2021 Oppenheimer Downgrades Invitae to Perform Rating Jan 29, 2021 Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss Jan 22, 2021 Invitae Prices $400M Common Stock Offering Jan 20, 2021 Invitae to Raise $400M in Proposed Public Offering Jan 14, 2021 Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan Jan 14, 2021 Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Jan 13, 2021 Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform Jan 11, 2021 Invitae 2020 Preliminary Revenues Rise 28 Percent Dec 28, 2020 M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 23, 2020 FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic Nov 9, 2020 Invitae, Passage Bio Collaborate on GM1 Genetic Testing, Clinical Trial Education Nov 5, 2020 Invitae Q3 Revenues Increase 22 Percent Oct 30, 2020 Broad Genetic Testing Uncovers Additional Risk Variants in Cancer Patients, Study Finds Oct 22, 2020 Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing Oct 14, 2020 JP Morgan Rates Invitae Neutral Oct 8, 2020 Germline Genetic Testing After Tumor Sequencing Can Uncover Clinically Actionable Variants Load More Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.